Cargando…
Extracellular Vesicles Released by Genetically Modified Macrophages Activate Autophagy and Produce Potent Neuroprotection in Mouse Model of Lysosomal Storage Disorder, Batten Disease
Over the recent decades, the use of extracellular vesicles (EVs) has attracted considerable attention. Herein, we report the development of a novel EV-based drug delivery system for the transport of the lysosomal enzyme tripeptidyl peptidase-1 (TPP1) to treat Batten disease (BD). Endogenous loading...
Autores principales: | El-Hage, Nazira, Haney, Matthew J., Zhao, Yuling, Rodriguez, Myosotys, Wu, Zhanhong, Liu, Mori, Swain, Carson J., Yuan, Hong, Batrakova, Elena V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252192/ https://www.ncbi.nlm.nih.gov/pubmed/37296618 http://dx.doi.org/10.3390/cells12111497 |
Ejemplares similares
-
Extracellular Vesicles as Drug Carriers for Enzyme Replacement Therapy to Treat CLN2 Batten Disease: Optimization of Drug Administration Routes
por: Haney, Matthew J., et al.
Publicado: (2020) -
Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson Disease
por: Zhao, Yuling, et al.
Publicado: (2022) -
Implication of the Autophagy-Related Protein Beclin1 in the Regulation of EcoHIV Replication and Inflammatory Responses
por: Rodriguez, Myosotys, et al.
Publicado: (2023) -
Targeting Beclin1 as an Adjunctive Therapy against HIV Using Mannosylated Polyethylenimine Nanoparticles
por: Rodriguez, Myosotys, et al.
Publicado: (2021) -
GDNF-Transfected Macrophages Produce Potent Neuroprotective Effects in Parkinson's Disease Mouse Model
por: Zhao, Yuling, et al.
Publicado: (2014)